nodes	percent_of_prediction	percent_of_DWPC	metapath
Latanoprost—Embolism—Thiotepa—sarcoma	0.0357	0.0373	CcSEcCtD
Latanoprost—Photophobia—Thiotepa—sarcoma	0.0215	0.0225	CcSEcCtD
Latanoprost—Inflammation—Etoposide—sarcoma	0.017	0.0177	CcSEcCtD
Latanoprost—Toxic epidermal necrolysis—Dactinomycin—sarcoma	0.0149	0.0155	CcSEcCtD
Latanoprost—Embolism—Epirubicin—sarcoma	0.0144	0.015	CcSEcCtD
Latanoprost—Keratitis—Epirubicin—sarcoma	0.0142	0.0149	CcSEcCtD
Latanoprost—Embolism—Doxorubicin—sarcoma	0.0133	0.0139	CcSEcCtD
Latanoprost—Keratitis—Doxorubicin—sarcoma	0.0132	0.0137	CcSEcCtD
Latanoprost—Dermatitis atopic—Epirubicin—sarcoma	0.0125	0.013	CcSEcCtD
Latanoprost—Conjunctivitis—Thiotepa—sarcoma	0.0125	0.013	CcSEcCtD
Latanoprost—Upper respiratory tract infection—Mitoxantrone—sarcoma	0.0115	0.0121	CcSEcCtD
Latanoprost—Dermatitis atopic—Doxorubicin—sarcoma	0.0115	0.012	CcSEcCtD
Latanoprost—Stinging—Epirubicin—sarcoma	0.0114	0.0119	CcSEcCtD
Latanoprost—Connective tissue disorder—Thiotepa—sarcoma	0.0113	0.0118	CcSEcCtD
Latanoprost—Urinary tract infection—Mitoxantrone—sarcoma	0.0108	0.0112	CcSEcCtD
Latanoprost—Conjunctivitis—Mitoxantrone—sarcoma	0.0108	0.0112	CcSEcCtD
Latanoprost—Toxic epidermal necrolysis—Etoposide—sarcoma	0.0108	0.0112	CcSEcCtD
Latanoprost—Stinging—Doxorubicin—sarcoma	0.0105	0.011	CcSEcCtD
Latanoprost—Mediastinal disorder—Thiotepa—sarcoma	0.0104	0.0108	CcSEcCtD
Latanoprost—Connective tissue disorder—Vincristine—sarcoma	0.01	0.0105	CcSEcCtD
Latanoprost—Erythema—Thiotepa—sarcoma	0.01	0.0105	CcSEcCtD
Latanoprost—Lacrimation increased—Epirubicin—sarcoma	0.01	0.0105	CcSEcCtD
Latanoprost—Erythema—Dactinomycin—sarcoma	0.00993	0.0104	CcSEcCtD
Latanoprost—Back pain—Thiotepa—sarcoma	0.00968	0.0101	CcSEcCtD
Latanoprost—Inflammation—Epirubicin—sarcoma	0.00951	0.00993	CcSEcCtD
Latanoprost—Vision blurred—Thiotepa—sarcoma	0.00943	0.00986	CcSEcCtD
Latanoprost—Lacrimation increased—Doxorubicin—sarcoma	0.00926	0.00968	CcSEcCtD
Latanoprost—Mediastinal disorder—Vincristine—sarcoma	0.00919	0.0096	CcSEcCtD
Latanoprost—Inflammation—Doxorubicin—sarcoma	0.00879	0.00919	CcSEcCtD
Latanoprost—Erythema—Mitoxantrone—sarcoma	0.00864	0.00903	CcSEcCtD
Latanoprost—Back pain—Vincristine—sarcoma	0.00859	0.00897	CcSEcCtD
Latanoprost—Arthralgia—Thiotepa—sarcoma	0.00852	0.00891	CcSEcCtD
Latanoprost—Dry eye—Epirubicin—sarcoma	0.00852	0.0089	CcSEcCtD
Latanoprost—Unspecified disorder of skin and subcutaneous tissue—Thiotepa—sarcoma	0.00846	0.00885	CcSEcCtD
Latanoprost—Back pain—Mitoxantrone—sarcoma	0.00836	0.00874	CcSEcCtD
Latanoprost—Discomfort—Dactinomycin—sarcoma	0.00836	0.00873	CcSEcCtD
Latanoprost—Vision blurred—Mitoxantrone—sarcoma	0.00815	0.00851	CcSEcCtD
Latanoprost—Oedema—Dactinomycin—sarcoma	0.00811	0.00847	CcSEcCtD
Latanoprost—Nervous system disorder—Thiotepa—sarcoma	0.00801	0.00837	CcSEcCtD
Latanoprost—Skin disorder—Thiotepa—sarcoma	0.00794	0.00829	CcSEcCtD
Latanoprost—Dry eye—Doxorubicin—sarcoma	0.00788	0.00824	CcSEcCtD
Latanoprost—Hepatic function abnormal—Epirubicin—sarcoma	0.00766	0.008	CcSEcCtD
Latanoprost—Eczema—Epirubicin—sarcoma	0.00745	0.00778	CcSEcCtD
Latanoprost—Mediastinal disorder—Etoposide—sarcoma	0.00744	0.00778	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Thiotepa—sarcoma	0.00744	0.00778	CcSEcCtD
Latanoprost—Eye pain—Epirubicin—sarcoma	0.00741	0.00775	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Dactinomycin—sarcoma	0.00739	0.00772	CcSEcCtD
Latanoprost—Arthralgia—Mitoxantrone—sarcoma	0.00736	0.00769	CcSEcCtD
Latanoprost—Chest pain—Mitoxantrone—sarcoma	0.00736	0.00769	CcSEcCtD
Latanoprost—Discomfort—Mitoxantrone—sarcoma	0.00727	0.0076	CcSEcCtD
Latanoprost—Oedema—Vincristine—sarcoma	0.00724	0.00757	CcSEcCtD
Latanoprost—Nervous system disorder—Vincristine—sarcoma	0.0071	0.00742	CcSEcCtD
Latanoprost—Hepatic function abnormal—Doxorubicin—sarcoma	0.00709	0.00741	CcSEcCtD
Latanoprost—Oedema—Mitoxantrone—sarcoma	0.00705	0.00737	CcSEcCtD
Latanoprost—Pain—Thiotepa—sarcoma	0.00699	0.0073	CcSEcCtD
Latanoprost—Back pain—Etoposide—sarcoma	0.00696	0.00727	CcSEcCtD
Latanoprost—Pain—Dactinomycin—sarcoma	0.00693	0.00725	CcSEcCtD
Latanoprost—Eczema—Doxorubicin—sarcoma	0.00689	0.0072	CcSEcCtD
Latanoprost—Eye pain—Doxorubicin—sarcoma	0.00686	0.00717	CcSEcCtD
Latanoprost—Skin disorder—Mitoxantrone—sarcoma	0.00685	0.00716	CcSEcCtD
Latanoprost—Diplopia—Epirubicin—sarcoma	0.00669	0.00699	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Vincristine—sarcoma	0.0066	0.0069	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.00643	0.00672	CcSEcCtD
Latanoprost—Dyspnoea—Mitoxantrone—sarcoma	0.00629	0.00657	CcSEcCtD
Latanoprost—Pain—Vincristine—sarcoma	0.00619	0.00647	CcSEcCtD
Latanoprost—Diplopia—Doxorubicin—sarcoma	0.00619	0.00647	CcSEcCtD
Latanoprost—Chest pain—Etoposide—sarcoma	0.00612	0.0064	CcSEcCtD
Latanoprost—PTGFR—myometrium—sarcoma	0.0061	0.141	CbGeAlD
Latanoprost—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.00608	0.00635	CcSEcCtD
Latanoprost—Discomfort—Etoposide—sarcoma	0.00605	0.00632	CcSEcCtD
Latanoprost—Pain—Mitoxantrone—sarcoma	0.00603	0.00631	CcSEcCtD
Latanoprost—Toxic epidermal necrolysis—Epirubicin—sarcoma	0.00603	0.0063	CcSEcCtD
Latanoprost—Asthma—Epirubicin—sarcoma	0.00578	0.00605	CcSEcCtD
Latanoprost—Pruritus—Thiotepa—sarcoma	0.00578	0.00604	CcSEcCtD
Latanoprost—Skin disorder—Etoposide—sarcoma	0.0057	0.00596	CcSEcCtD
Latanoprost—Angina pectoris—Epirubicin—sarcoma	0.00563	0.00589	CcSEcCtD
Latanoprost—Toxic epidermal necrolysis—Doxorubicin—sarcoma	0.00558	0.00583	CcSEcCtD
Latanoprost—Bronchitis—Epirubicin—sarcoma	0.00556	0.00581	CcSEcCtD
Latanoprost—Dizziness—Thiotepa—sarcoma	0.0054	0.00565	CcSEcCtD
Latanoprost—Upper respiratory tract infection—Epirubicin—sarcoma	0.00538	0.00562	CcSEcCtD
Latanoprost—Asthma—Doxorubicin—sarcoma	0.00535	0.00559	CcSEcCtD
Latanoprost—Dyspnoea—Etoposide—sarcoma	0.00523	0.00547	CcSEcCtD
Latanoprost—Angina pectoris—Doxorubicin—sarcoma	0.00521	0.00545	CcSEcCtD
Latanoprost—Rash—Thiotepa—sarcoma	0.00515	0.00538	CcSEcCtD
Latanoprost—Bronchitis—Doxorubicin—sarcoma	0.00515	0.00538	CcSEcCtD
Latanoprost—Dermatitis—Thiotepa—sarcoma	0.00515	0.00538	CcSEcCtD
Latanoprost—Headache—Thiotepa—sarcoma	0.00512	0.00535	CcSEcCtD
Latanoprost—Rash—Dactinomycin—sarcoma	0.00511	0.00534	CcSEcCtD
Latanoprost—Pain—Etoposide—sarcoma	0.00502	0.00524	CcSEcCtD
Latanoprost—Urinary tract infection—Epirubicin—sarcoma	0.00501	0.00524	CcSEcCtD
Latanoprost—Conjunctivitis—Epirubicin—sarcoma	0.00501	0.00524	CcSEcCtD
Latanoprost—Upper respiratory tract infection—Doxorubicin—sarcoma	0.00497	0.0052	CcSEcCtD
Latanoprost—Dizziness—Vincristine—sarcoma	0.00479	0.00501	CcSEcCtD
Latanoprost—SLCO2B1—mammary gland—sarcoma	0.00474	0.11	CbGeAlD
Latanoprost—Urinary tract infection—Doxorubicin—sarcoma	0.00464	0.00485	CcSEcCtD
Latanoprost—Conjunctivitis—Doxorubicin—sarcoma	0.00464	0.00485	CcSEcCtD
Latanoprost—PTGFR—smooth muscle tissue—sarcoma	0.00461	0.107	CbGeAlD
Latanoprost—Rash—Vincristine—sarcoma	0.00457	0.00477	CcSEcCtD
Latanoprost—Dermatitis—Vincristine—sarcoma	0.00456	0.00477	CcSEcCtD
Latanoprost—Connective tissue disorder—Epirubicin—sarcoma	0.00455	0.00476	CcSEcCtD
Latanoprost—Headache—Vincristine—sarcoma	0.00454	0.00474	CcSEcCtD
Latanoprost—Rash—Mitoxantrone—sarcoma	0.00445	0.00465	CcSEcCtD
Latanoprost—Dermatitis—Mitoxantrone—sarcoma	0.00444	0.00464	CcSEcCtD
Latanoprost—Headache—Mitoxantrone—sarcoma	0.00442	0.00462	CcSEcCtD
Latanoprost—Connective tissue disorder—Doxorubicin—sarcoma	0.00421	0.0044	CcSEcCtD
Latanoprost—Mediastinal disorder—Epirubicin—sarcoma	0.00417	0.00436	CcSEcCtD
Latanoprost—Pruritus—Etoposide—sarcoma	0.00415	0.00434	CcSEcCtD
Latanoprost—Erythema—Epirubicin—sarcoma	0.00403	0.00421	CcSEcCtD
Latanoprost—PTGFR—uterus—sarcoma	0.00396	0.0916	CbGeAlD
Latanoprost—Back pain—Epirubicin—sarcoma	0.0039	0.00407	CcSEcCtD
Latanoprost—Dizziness—Etoposide—sarcoma	0.00388	0.00406	CcSEcCtD
Latanoprost—Mediastinal disorder—Doxorubicin—sarcoma	0.00386	0.00404	CcSEcCtD
Latanoprost—Vision blurred—Epirubicin—sarcoma	0.0038	0.00397	CcSEcCtD
Latanoprost—Erythema—Doxorubicin—sarcoma	0.00373	0.0039	CcSEcCtD
Latanoprost—Rash—Etoposide—sarcoma	0.0037	0.00387	CcSEcCtD
Latanoprost—Dermatitis—Etoposide—sarcoma	0.0037	0.00386	CcSEcCtD
Latanoprost—Headache—Etoposide—sarcoma	0.00368	0.00384	CcSEcCtD
Latanoprost—Back pain—Doxorubicin—sarcoma	0.00361	0.00377	CcSEcCtD
Latanoprost—Vision blurred—Doxorubicin—sarcoma	0.00351	0.00367	CcSEcCtD
Latanoprost—PTGFR—tendon—sarcoma	0.00347	0.0803	CbGeAlD
Latanoprost—Arthralgia—Epirubicin—sarcoma	0.00343	0.00359	CcSEcCtD
Latanoprost—Chest pain—Epirubicin—sarcoma	0.00343	0.00359	CcSEcCtD
Latanoprost—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.00341	0.00356	CcSEcCtD
Latanoprost—Discomfort—Epirubicin—sarcoma	0.00339	0.00354	CcSEcCtD
Latanoprost—Oedema—Epirubicin—sarcoma	0.00329	0.00344	CcSEcCtD
Latanoprost—Nervous system disorder—Epirubicin—sarcoma	0.00323	0.00337	CcSEcCtD
Latanoprost—Skin disorder—Epirubicin—sarcoma	0.0032	0.00334	CcSEcCtD
Latanoprost—Chest pain—Doxorubicin—sarcoma	0.00317	0.00332	CcSEcCtD
Latanoprost—Arthralgia—Doxorubicin—sarcoma	0.00317	0.00332	CcSEcCtD
Latanoprost—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.00315	0.0033	CcSEcCtD
Latanoprost—Discomfort—Doxorubicin—sarcoma	0.00314	0.00328	CcSEcCtD
Latanoprost—Oedema—Doxorubicin—sarcoma	0.00304	0.00318	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Epirubicin—sarcoma	0.003	0.00313	CcSEcCtD
Latanoprost—Nervous system disorder—Doxorubicin—sarcoma	0.00298	0.00312	CcSEcCtD
Latanoprost—Skin disorder—Doxorubicin—sarcoma	0.00296	0.00309	CcSEcCtD
Latanoprost—Dyspnoea—Epirubicin—sarcoma	0.00293	0.00307	CcSEcCtD
Latanoprost—SLCO2B1—hematopoietic system—sarcoma	0.00289	0.0669	CbGeAlD
Latanoprost—PTGFR—testis—sarcoma	0.00287	0.0665	CbGeAlD
Latanoprost—Pain—Epirubicin—sarcoma	0.00281	0.00294	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.00277	0.0029	CcSEcCtD
Latanoprost—PTGFR—liver—sarcoma	0.00271	0.0628	CbGeAlD
Latanoprost—Dyspnoea—Doxorubicin—sarcoma	0.00271	0.00284	CcSEcCtD
Latanoprost—Pain—Doxorubicin—sarcoma	0.0026	0.00272	CcSEcCtD
Latanoprost—Pruritus—Epirubicin—sarcoma	0.00233	0.00243	CcSEcCtD
Latanoprost—SLCO2B1—uterus—sarcoma	0.00218	0.0505	CbGeAlD
Latanoprost—Dizziness—Epirubicin—sarcoma	0.00218	0.00227	CcSEcCtD
Latanoprost—Pruritus—Doxorubicin—sarcoma	0.00215	0.00225	CcSEcCtD
Latanoprost—PTGFR—lymph node—sarcoma	0.00208	0.0482	CbGeAlD
Latanoprost—Rash—Epirubicin—sarcoma	0.00207	0.00217	CcSEcCtD
Latanoprost—Dermatitis—Epirubicin—sarcoma	0.00207	0.00217	CcSEcCtD
Latanoprost—Headache—Epirubicin—sarcoma	0.00206	0.00215	CcSEcCtD
Latanoprost—Dizziness—Doxorubicin—sarcoma	0.00201	0.0021	CcSEcCtD
Latanoprost—Rash—Doxorubicin—sarcoma	0.00192	0.00201	CcSEcCtD
Latanoprost—Dermatitis—Doxorubicin—sarcoma	0.00192	0.002	CcSEcCtD
Latanoprost—SLCO2B1—tendon—sarcoma	0.00191	0.0443	CbGeAlD
Latanoprost—Headache—Doxorubicin—sarcoma	0.00191	0.00199	CcSEcCtD
Latanoprost—SLCO2B1—testis—sarcoma	0.00158	0.0367	CbGeAlD
Latanoprost—SLCO2B1—liver—sarcoma	0.0015	0.0347	CbGeAlD
Latanoprost—SLC22A1—liver—sarcoma	0.00143	0.0331	CbGeAlD
Latanoprost—SLCO2B1—lymph node—sarcoma	0.00115	0.0266	CbGeAlD
